Respiratory symptoms in severe allergic reactions to food: data from the Norwegian national reporting system and register of severe allergic reactions to food

M. Løvik, H. G. Wiker, B. Gondrosen, G. Omholt-Jensen (Oslo, Norway)

Source: Annual Congress 2002 - The development of allergic sensitization / asthma in children
Session: The development of allergic sensitization / asthma in children
Session type: Thematic Poster Session
Number: 788
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Abstract

The prevalence of food allergy in Norway is unknown. Also, little is known about risk groups, offending foods, the circumstances under which the reactions occur, and the frequency and significance of different symptoms. As part of the Government Action Plan against asthma, allergy and indoor-air-related diseases, funding has been provided from the year 2000 on for a national reporting system and register of severe allergic reactions to food. The purpose is to obtain statistical information about severe allergic reactions to food, to offer supplementary serologic analyses, to offer food allergen analyses when relevant, and to offer reporting doctors advice and information.
The reporting system was launched July 1, 2000. By December 2001 about 100 cases had been reported. There was a marked peak of cases among young adults, with no significant gender difference. About 50% of cases had an onset of symptoms within 30 minutes of food intake. Sixty-three per cent had known allegies, 55% known food allergy, while 26% had known asthma. Among cases where relevant information was given, most of the cases experienced their reaction at a restaurant or at a party or visit away from home. The most common incriminating foods were peanuts/nuts, fish and shellfish. Serologically (specific IgE), peanuts, hazelnuts, and shellfish were the three most common foods. The most common first symptoms were swelling/oedema, urticaria, pruritus, gastrointestinal symptoms, rash/rubor, and respiratory symptoms, in that order.
Asthma is considered a risk factor for serious food allergic reactions, and it has been claimed that in lethal food anaphylactic reactions most patients do not die from shock, but from respiratory problems. In our material (no deaths) respiratory symptoms were relatively infrequent, at least as an early symptom.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Løvik, H. G. Wiker, B. Gondrosen, G. Omholt-Jensen (Oslo, Norway). Respiratory symptoms in severe allergic reactions to food: data from the Norwegian national reporting system and register of severe allergic reactions to food. Eur Respir J 2002; 20: Suppl. 38, 788

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Common food allergens in children with respiratory allergic symptoms
Source: Eur Respir J 2003; 22: Suppl. 45, 136s
Year: 2003

Is prevalence of asthma, respiratory symptoms and allergic sensitisation still increasing in Swedish children?
Source: Annual Congress 2007 - Allergy and asthma - environmental and metabolic risk factors
Year: 2007


Associations between food allergy and respiratory manifestations in a population-based sample of children
Source: Eur Respir J 2004; 24: Suppl. 48, 170s
Year: 2004

Asthma and allergic rhinitis increase respiratory symptoms and disability in cold weather
Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors
Year: 2018

Fewer allergic respiratory disorders among farmers' children in a closed birth cohort from Sweden
Source: Eur Respir J 2001; 17: 1151-1157
Year: 2001



The German severe asthma register
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012

Swimming pool attendance and risk of asthma and allergic symptoms in children
Source: Eur Respir J 2009; 34: 1304-1310
Year: 2009



Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Pooled data from 3 UK centres
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011

Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Pooled data from 4 UK centres
Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE
Year: 2012


Long-term effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Real-life data from 3 UK centres
Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE
Year: 2012


Prevalence estimates of current asthma and chronic cough/phlegm, but not of allergic rhinitis, are strongly related to response percentage in a mail survey
Source: Eur Respir J 2007; 30: Suppl. 51, 149s
Year: 2007

Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma at a single UK hospital
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Should patients with mild asthma be excluded from allergic rhinitis drug trials?
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015


The co-morbidity of allergic hay fever, asthma and related disorders in randomly selected patients with respiratory allergic diseases
Source: Annual Congress 2005 - Environmental factors, allergy and asthma
Year: 2005


The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta
Source: International Congress 2016 – Asthma management
Year: 2016


Effect of omalizumab treatment on allergic comorbidities in patients with severe allergic asthma – real life experience from Czech Anti-IgE Registry
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

Time trends in clinical characteristics of patients with severe asthma: data from the Belgian Severe asthma register (BSAR)
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018

Drug hypersensitivity and food allergy in subjects with persistent asthma
Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function?
Year: 2009

Childhood allergic sensitisation and respiratory manifestations. 6C study-France
Source: Eur Respir J 2007; 30: Suppl. 51, 399s
Year: 2007

Respiratory symptoms and asthma among swimming pool workers – results from a questionnaire study
Source: Annual Congress 2008 - Epidemiology of asthma and allergy
Year: 2008